Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 2/12/2025CDE Issues the List of Reference Formulations for GQCE Studies (90th B...
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/12/2025FDA Issues Warning Letters to Two Chinese API Manufacturers
  • 2/12/2025Pfizer and CSPC Pharma Partner to Launch Localized Oral COVID-19 Treat...
  • 2/12/2025Merck Registers Kelun's Nectin-4 ADC MK-3120 and Initiates Phase 1 Tri...
  • 2/11/2025JNJ Receives Approval in China for Two Novel BsAbs
  • 2/11/2025CARsgen's First Subject in THANK-u Plus™ Allogeneic CAR-T Trial Achie...
  • 2/11/2025China's Health Regulator Defends Quality of Domestic Generic Drugs  
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/11/2025IVIEW Reports Positive Phase 1/2 Results for IVW-1001 Ophthalmic Eyeli...
  • 2/11/2025Bio-Thera Enters License Pact with Intas Pharma for Simponi® Biosim...
  • 2/11/2025Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...
  • 2/11/2025Regend Secures Series B+ Financing to Advance Stem Cell-Based Regenera...
  • 2/11/2025XtalPi Announces Strategic Investment and Collaboration with Alternati...
  • 2/11/2025BioKin Pharma's HER2 ADC BL-M07D1 Advances to Phase III in China
  • 2/10/2025CDE Releases Two Guidelines for Acceptance and Review of Chemical and ...
  • 2/10/2025CDE Issues the Technical Guidelines for the Use of Patient-Reported Ou...
  • 2/10/2025CDE Issues the Technical Guidelines for Clinical Trials of Gene Therap...
  • 2/10/2025CDE Issues the Technical Guidelines for Writing Biosimilar Drug Packag...
  • 2/10/2025Kelun-Biotech's Cetuximab Biosimilar Receives NMPA Approval for First-...
  • 2/10/2025Hexaell Biotech Completes CNY 200M Series B+ Financing to Accelerate L...
  • 2/10/2025NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
  • 2/10/2025Sunshine Lake Pharma's NS5A Inhibitor Netanasvir Phosphate Approved in...
  • 2/7/2025Recent Executive Moves
  • 2/7/2025Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
  • 2/7/2025Toll Biotech Secures FDA and NMPA IND Approvals for TLR8 Modulator Tol...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 2/6/2025Roche Reports Strong 2024 Growth with China Sales Reaching $6.1 Billio...
  • Page:10/47 Total number of articles:1389: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group